Instrument Inactif

Communiqués BioSpecifics Technologies Corp.

Actions

BSTC

US0909311062

Recherche biotechnologique et médicale

Communiqués

02/12/20	BIOSPECIFICS TECHNOLOGIES CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
19/11/20	BioSpecifics Technologies : Endo Announces Expiration of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer	AQ
18/11/20	BioSpecifics Technologies : Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer	AQ
10/11/20	BioSpecifics Technologies : Reports Third Quarter 2020 Financial and Operating Results	AQ
09/11/20	BIOSPECIFICS TECHNOLOGIES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
09/11/20	BioSpecifics: 3Q Earnings Snapshot	AQ
09/11/20	BioSpecifics Technologies : Reports Third Quarter 2020 Financial and Operating Results	PR
06/11/20	BioSpecifics Technologies : Endo Reports Third-Quarter 2020 Financial Results and Raises Full Year 2020 Financial Guidance	AQ
03/11/20	BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC	BU
03/11/20	BioSpecifics Technologies : Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.	AQ
02/11/20	BioSpecifics Technologies : Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.	AQ
26/10/20	BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC	BU
20/10/20	BioSpecifics Technologies : Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX and Qwo	AQ
20/10/20	BioSpecifics Technologies : to be acquired by Endo Pharmaceuticals	AQ
19/10/20	BIOSPECIFICS TECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
19/10/20	BioSpecifics Technologies : Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™	AQ
15/09/20	BioSpecifics Technologies : to Present at the Virtual Oppenheimer and Co. Fall Healthcare Life Sciences and MedTech Summit	AQ
14/09/20	BIOSPECIFICS TECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
14/09/20	BioSpecifics Technologies : to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit	PR
08/09/20	BioSpecifics Technologies : to Present at the H.C. Wainwright Virtual Healthcare Conference	PR
31/08/20	BIOSPECIFICS TECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
11/08/20	BIOSPECIFICS TECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
10/08/20	BIOSPECIFICS TECHNOLOGIES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
10/08/20	BioSpecifics: 2Q Earnings Snapshot	AQ
10/08/20	BioSpecifics Technologies : Reports Second Quarter 2020 Financial and Operating Results	PR